Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Preferred Stock Liabilities (2021 - 2025)

Hypha Labs filings provide 5 years of Preferred Stock Liabilities readings, the most recent being $333600.0 for Q3 2025.

  • On a quarterly basis, Preferred Stock Liabilities changed 0.0% to $333600.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $333600.0, a 0.0% change, with the full-year FY2025 number at $333600.0, changed 0.0% from a year prior.
  • Preferred Stock Liabilities hit $333600.0 in Q3 2025 for Hypha Labs, roughly flat from $333600.0 in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $333600.0 in Q4 2021 to a low of $333600.0 in Q4 2021.
  • Median Preferred Stock Liabilities over the past 5 years was $333600.0 (2021), compared with a mean of $333600.0.
  • The widest YoY moves for Preferred Stock Liabilities: up 0.0% in 2022, down 0.0% in 2022.
  • Hypha Labs' Preferred Stock Liabilities stood at $333600.0 in 2021, then changed by 0.0% to $333600.0 in 2022, then changed by 0.0% to $333600.0 in 2023, then changed by 0.0% to $333600.0 in 2024, then changed by 0.0% to $333600.0 in 2025.
  • The last three reported values for Preferred Stock Liabilities were $333600.0 (Q3 2025), $333600.0 (Q2 2025), and $333600.0 (Q1 2025) per Business Quant data.